null

Aflibercept (Eylea®)Antibody screening - Qualitative ELISA Kit

SKU:
HUMB00055
Product Type:
ELISA Kit
ELISA Type:
Biosimilar ELISA
Biosimilar ELISA Type:
Qualitative
Applications:
ELISA
Reactivity:
Human
Analytes:
Aflibercept (Eylea®)
Research Area:
Anti-Cancer
Wet AMD
€1,049
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

Aflibercept (Eylea®) Antibody screening - Qualitative ELISA Kit

Assay Genie Qualitative Antibodies to Aflibercept ELISA has been especially developed for the qualitative analysis of antibodies to aflibercept in serum and plasma samples. Assay Genie Qualitative Antibodies to Aflibercept ELISA is optimized with Eylea®.

Aflibercept (Eylea®) Antibody screening - Qualitative ELISA Kit test principle

Solid phase enzyme-linked immunosorbent assay (ELISA) based on the sandwich principle. Controls and samples (serum or plasma) are incubated in the microtiter plate coated with the drug aflibercept. After incubation, the wells are washed. Then, horseradish peroxidase (HRP) conjugated probe is added and binds to aflibercept antibodies captured by the drug aflibercept on the surface of the wells. Following incubation wells are washed and the bound enzymatic activity is detected by addition of chromogen-substrate. Finally, the reaction is terminated with an acidic stop solution. The colour developed is proportional to the amount of aflibercept antibodies in the sample or controls. The results can be evaluated with using cutoff value.

Aflibercept (Eylea®) Antibody screening - Qualitative ELISA Kit product information

Key InformationDescription

Application

Antibody screening- Qualitative

Required Volume

10 µl

Total Time

140 minutes

Sample Type

Serum, Plasma

Number of Assays

96

Detection Limit

+ / - ng/mL

Spike Recovery

-

Shelf Life (years)

1

Alternative Names

-

About Aflibercept (Eylea®) Antibody screening - Qualitative ELISA Kit

Aflibercept is a recombinant protein composed of the binding domains of two human vascular endothelial growth factor
(VEGF) receptors fused with the Fc region of human immunoglobulin gamma 1 (IgG1). Aflibercept, as an ophthalmic agent, is used in the treatment of macular edema following Central Retinal Vein Occlusion (CRVO) and neovascular Age-Related Macular Degeneration (AMD). Compared to other anti-VEGF drugs like bevacizumab and ranibizumab, aflibercept has a higher binding affinity to VEGF-A.
Assay Genie kits can be used for drug level and anti-drug antibodies measurements.

Assay Genie Aflibercept ELISA products:

ProductApplicationSKU

Aflibercept (Eylea®)

Free Drug

Aflibercept (Eylea®)

Antibody screening - Qualitative

Eylea® is a trademark of Regeneron Pharmaceuticals Inc.